News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Tananbaum James B.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/19/2023 |
4
| Foresite Capital Management V, LLC (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 523,450 shares
@ $2.97, valued at
$1.6M
Bought 176,550 shares
@ $2.97, valued at
$524.4k
|
|
| 05/10/2023 |
4
| Tananbaum James B. (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Bought 1,550,956 shares
@ $2.8, valued at
$4.3M
Bought 229,044 shares
@ $2.8, valued at
$641.3k
|
|
| 02/22/2023 |
4
| Tananbaum James B. (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Acquired 1,100,000 shares
@ $0 |
|
| 01/03/2023 |
4
| Foresite Capital Management V, LLC (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 250,000 shares
@ $5, valued at
$1.3M
Bought 250,000 shares
@ $5, valued at
$1.3M
|
|
| 12/05/2022 |
4
| Foresite Capital Management V, LLC (10% Owner) has filed a Form 4 on PARDES BIOSCIENCES, INC.|
Txns:
| Bought 637,420 shares
@ $0.85, valued at
$541.8k
|
|
| 06/15/2022 |
4
| Tananbaum James B. (Director) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 20,250 options to buy
@ $8.38, valued at
$169.7k
|
|
| 06/13/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/30/2021 |
4/A
| Tananbaum James B. (10% Owner) has filed a Form 4 on PARDES BIOSCIENCES, INC.|
Txns:
| Converted 4,941,250 shares
@ $0
Converted 4,941,250 options to buy
@ $0 |
|
| 12/28/2021 |
4
| Tananbaum James B. (10% Owner) has filed a Form 4 on PARDES BIOSCIENCES, INC.|
Txns:
| Granted 1,000,000 shares
@ $10, valued at
$10M
Converted 4,873,750 shares
@ $0
Granted 7,759,072 shares
@ $0
Converted 4,873,750 options to buy
@ $0
Granted 75,000 options to buy
@ $9.8, valued at
$735k
|
|
| 12/23/2021 |
4
| Tananbaum James B. (10% Owner) has filed a Form 4 on PARDES BIOSCIENCES, INC.|
Txns:
| Bought 325,000 shares
@ $10, valued at
$3.3M
|
|
| 11/03/2021 |
4
| Foresite Capital Management III, LLC (10% Owner) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Disposed of 1,954,904 shares
@ $0
Acquired 8,276 shares
@ $0 |
|
| 10/06/2021 |
4
| Tananbaum James B. (10% Owner) has filed a Form 4 on Gemini Therapeutics, Inc. /DE|
Txns:
| Granted 17,245 options to buy
@ $3.8, valued at
$65.5k
|
|
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/23/2021 |
4
| FS Development Holdings II, LLC (10% Owner) has filed a Form 4 on FS Development Corp. II|
Txns:
| Bought 602,500 shares
@ $10, valued at
$6M
|
|
| 02/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/10/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/09/2021 |
4
| Tananbaum James B. (Director) has filed a Form 4 on Gemini Therapeutics, Inc. /DE|
Txns:
| Granted 1,500,000 shares
@ $10, valued at
$15M
Converted 2,928,750 shares
@ $0
Converted 2,928,750 options to buy
@ $0 |
|
| 12/09/2020 |
4
| Tananbaum James B. (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Converted 9,171,643 shares
@ $0
Converted 500,001 shares
@ $0
Converted 166,667 shares
@ $0
Converted 6,347,893 preferred shares
@ $0
Converted 298,465 preferred shares
@ $0
Converted 99,488 preferred shares
@ $0
Converted 2,666,002 preferred shares
@ $0
Converted 55,922 preferred shares
@ $0
Converted 18,641 preferred shares
@ $0
Converted 157,222 preferred shares
@ $0
Converted 145,128 preferred shares
@ $0 |
|
| 12/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/19/2020 |
4
| FS Development Holdings, LLC (10% Owner) has filed a Form 4 on FS Development Corp.|
Txns:
| Bought 441,500 shares
@ $10, valued at
$4.4M
|
|
| 08/19/2020 |
3/A
| Tananbaum James B. (President & CEO) has filed a Form 3/A on FS Development Corp. |
| 08/11/2020 |
3
| Tananbaum James B. (President and CEO) has filed a Form 3 on FS Development Corp. |
| 05/14/2020 |
4
| Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Converted 1,930,198 shares
@ $0
Sold 800,000 shares
@ $80.13, valued at
$64.1M
Sold 650,000 shares
@ $80.13, valued at
$52.1M
Converted 1,930,198 options to buy
@ $0 |
|
| 05/08/2020 |
4
| Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Converted 500,000 shares
@ $0
Converted 1,500,000 shares
@ $0
Converted 500,000 options to buy
@ $0
Converted 1,500,000 options to buy
@ $0 |
|
| 04/24/2020 |
4
| Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Disposed of 700,000 shares
@ $0
Acquired 178,584 shares
@ $0
Disposed of 178,584 shares
@ $0
Acquired 92,258 shares
@ $0
Converted 1,000,000 shares
@ $0
Converted 1,000,000 options to buy
@ $0 |
|
| 04/15/2020 |
4
| Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Disposed of 788,317 shares
@ $0
Disposed of 433,725 shares
@ $0
Acquired 201,115 shares
@ $0
Disposed of 201,115 shares
@ $0
Acquired 21,686 shares
@ $0
Disposed of 21,686 shares
@ $0
Acquired 109,849 shares
@ $0
Converted 1,500,000 shares
@ $0
Converted 1,500,000 options to buy
@ $0 |
|
| 03/26/2020 |
4
| Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Converted 2,170,619 shares
@ $0
Converted 2,170,619 options to buy
@ $0 |
|
| 03/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|